Safety and Immunologic Activity of Multiple Infusions of APN401
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs APN 401 (Primary)
- Indications Colorectal cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- 09 Sep 2019 Planned End Date changed from 1 Oct 2019 to 1 May 2024.
- 09 Sep 2019 Planned primary completion date changed from 1 Oct 2019 to 22 May 2020.
- 09 Sep 2019 Status changed from suspended to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History